SynthesisBMC ophthalmology2026

Assessing the risk of diabetic retinopathy progression with GLP-1 receptor agonists: a systematic review and meta-analysis.

Qian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.